Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Research explores the cost-effectiveness of Sweden's national vaccination programs

Immunizing children against chickenpox would save money, but offering shingles vaccinations to all 65-year-olds would not. These are examples of findings in a University of Gothenburg thesis exploring the cost-effectiveness of Sweden's national vaccination programs.

23 Dec 2020

Study measures the effects of HIV infection on development of cervical cancer

A research team at the Technical University of Munich (TUM) has quantified the effects of an infection with the Human Immunodeficiency Virus (HIV) on the development of cervical cancer.

22 Dec 2020

AAHMS report spells out the necessary steps to maintain control over COVID-19 in 2021

High levels of testing, efficient vaccine distribution and addressing pandemic mental health impacts are critical if Australia is to maintain control over COVID-19 in 2021, the country’s learned body for health and medical sciences has concluded.

18 Dec 2020

Pediatricians want kids to be part of COVID vaccine trials

If clinical trials for COVID-19 vaccines aren't expanded soon to include children, it's unlikely that even kids in their teens will be vaccinated in time for the next school year.

15 Dec 2020

Smartphone-based adherence program can optimize uptake of COVID-19 vaccine

The light at the end of the pandemic tunnel is getting brighter. This week, the first health care workers will receive the first doses of an FDA-approved coronavirus vaccine. Soon, so will other front-line workers in health care and beyond, and residents of long-term care facilities.

15 Dec 2020

COVID-19-related disruptions to cervical cancer screening could increase risk sevenfold, UK case study finds

A new study reveals inequalities in the delay in screening for cervical cancer, and recommends that the screening capacity be increased in addition to giving a higher priority to women who have missed their scheduled visit.

2 Dec 2020

UTHSC receives $1.25 million to conduct a study on improving adherence to HPV vaccine

The human papillomavirus (HPV) vaccine was introduced in the United States for preteens more than a dozen years ago, yet adherence rates are still below those for other childhood vaccines.

2 Dec 2020

Mobile health app can improve HPV vaccine uptake in adolescents

More than 90 percent of human papillomavirus (HPV)-related cancers could be prevented by widespread uptake of the HPV vaccine. Yet, vaccine use in the United States falls short of public health goals.

2 Dec 2020

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients.

16 Nov 2020

HPV vaccines found to be safe and well-tolerated in males

Human papillomavirus (HPV) is one of the most common sexually transmitted infections and cases various cancers in women and men.

4 Nov 2020

Social media policies can help control HPV vaccine misinformation, shows study

Human papillomavirus (HPV) is the most common sexually transmitted disease and the primary cause of several cancers. Recent estimates indicate that 70-90 percent of HPV-related cancers may be prevented through vaccination.

5 Oct 2020

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A new study published in the preprint server bioRxiv in September 2020 reports on the structure of this protein, as revealed by cryo-electron microscopy (cryoEM).

23 Sep 2020

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

The widespread use of antiretroviral therapy to suppress the HIV virus has helped tens of millions of people with HIV live healthier, longer lives--but an unfortunate consequence of people living longer with HIV is an increased risk of cancer.

22 Sep 2020

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

A new study published on the preprint server bioRxiv* in September 2020 reports on a Moloney murine leukemia virus (MLV) platform that produces VLPs expressing the important spike antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Sep 2020

De novo designed SARS-CoV-2 nanoparticle vaccine

In light of the continuing threat to public health, social functioning, and economic activity posed by the COVID-19 pandemic, scientists are working urgently to bring out a vaccine that is both safe and effective, and capable of mass production. A new paper published on the preprint server bioRxiv* in August 2020 shows that such a vaccine may be produced by using arrays of one severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) protein on a nanoparticle platform.

14 Aug 2020

HPV type may impact cervical cancer characteristics and prognosis

An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumors caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.

10 Aug 2020

Updated cervical cancer screening guideline calls for less and more simplified screening

An updated cervical cancer screening guideline from the American Cancer Society reflects the rapidly changing landscape of cervical cancer prevention in the United States, calling for less and more simplified screening. The guideline appears in the ACS's flagship journal, CA: A Cancer Journal for Clinicians.

30 Jul 2020